Cargando…
Immune Checkpoints: Therapeutic Targets for Pituitary Tumors
Pituitary tumors are the third most common intracranial tumors in adults. Treatment of refractory pituitary tumors is known to be difficult due to limited treatment options. As a promising therapeutic method, tumor immunotherapy has been applied in the treatment of many tumors, including pituitary t...
Autores principales: | Nie, Ding, Xue, Yimeng, Fang, Qiuyue, Cheng, Jianhua, Li, Bin, Wang, Dawei, Li, Chuzhong, Gui, Songbai, Zhang, Yazhuo, Zhao, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384513/ https://www.ncbi.nlm.nih.gov/pubmed/34447484 http://dx.doi.org/10.1155/2021/5300381 |
Ejemplares similares
-
Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
por: Nie, Ding, et al.
Publicado: (2021) -
The effect of endoscopic transsphenoidal somatotroph tumors resection on pituitary hormones: systematic review and meta-analysis
por: Nie, Ding, et al.
Publicado: (2023) -
Risk factors and management associated with postoperative cerebrospinal fluid leak after endoscopic endonasal surgery for pituitary adenoma
por: Li, Bin, et al.
Publicado: (2022) -
LncRNA PCAT6 regulates the progression of pituitary adenomas by regulating the miR-139-3p/BRD4 axis
por: Zhao, Peng, et al.
Publicado: (2021) -
The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor
por: Nie, Ding, et al.
Publicado: (2021)